Isofol Medical AB (publ) (STO:ISOFOL)
Sweden · Delayed Price · Currency is SEK 0.7800
+0.0240 (3.17%)
Sep 22, 2026, 5:24 PM CET
Isofol Medical AB Market Cap
Isofol Medical AB has a market cap or net worth of 249.98 million as of September 22, 2026. Its market cap has increased by 10.47% in one year.
Market Cap
249.98M
Enterprise Value
135.16M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.78
ChartMarket Cap Chart
Since April 4, 2017, Isofol Medical AB's market cap has decreased from 853.32M to 249.98M, a decrease of -70.70%. That is a compound annual growth rate of -12.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 249.98M | 21.99% |
| Dec 30, 2025 | 204.93M | -42.85% |
| Dec 30, 2024 | 358.56M | 204.11% |
| Dec 29, 2023 | 117.91M | -1.35% |
| Dec 30, 2022 | 119.52M | -91.99% |
| Dec 30, 2021 | 1.49B | -36.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cantargia AB | 388.33M |
| Corline Biomedical AB | 371.09M |
| Intervacc AB | 344.22M |
| Sprint Bioscience AB | 301.77M |
| IRLAB Therapeutics AB | 258.76M |
| Xbrane Biopharma AB | 219.45M |
| Elicera Therapeutics AB | 181.19M |
| Abera Bioscience AB | 159.48M |